Veravas announced it raised $775,000 in an initial filing from an offering of $50 Million
03/29/23, 7:21 PM
Location
austin
Money raised
$775,000
Industry
healthcare
Round Type
seed
Company Info
Location
111 congress ave. ste. 500
austin, texas, united states
Additional Info
Veravas™ is transforming laboratory diagnostics by making early detection of disease possible in any sample type including saliva.
This technology will have a profound impact on the performance and speed of development and facilitates the use of saline oral rinse (saliva-based) as an alternative to serum or plasma. Using this technology, Veravas is bringing high value tests to market in areas such as neurological diseases, cancer, cardiovascular, and infectious disease that have not been previously possible.
To learn more about our technologies and clinical applications, visit veravas.com